Table 2

Echocardiographic parameters comparing baseline readings with within a month and within a year after the start of anthracycline chemotherapy

Echocardiographic parametersBaseline readingsWithin a monthWithin a yearp Value
EF (%)69.9±4.367.3±5.362.6±9.6<0.001
FS (%)36.6±2.635.3±2.832.9±5.0<0.001
PWT (mm)6.7±1.35.8±1.15.4±1.1<0.001
IVS (mm)5.9±0.25.4±1.14.9±1.0<0.001
LVEDD (mm)34.5±5.635.8±5.437.3±5.8<0.001
LVESD (mm)22.0±4.223.4±4.425.3±5.4<0.001
E (cm/s)93.7±9.286.8±10.385.1±11.5<0.001
A (cm/s)58.9±6.563.5±7.564.6±9.1<0.001
E/A ratio1.6±1.81.38±0.211.3±.33<0.001
E′ (cm/s)14.1±2.412.2±2.311.1±2.5<0.001
E/E′ ratio6.7±1.057.17±1.18.1±2.6<0.001
Tei index (MPI)0.3±.050.4±.050.4±.07<0.001
DT164.3±15.3171.6±19.8174.7±28.9<0.001
  • A, peak flow velocity during atrial contraction; DT, E deceleration time; E, early diastolic mitral peak flow velocity; E′, peak early diastolic myocardial velocity; EF, ejection fraction; FS, fractioning shortening; IVS, interventricular wall thickness; LVEDD, left ventricular (LV) end diastolic diameter; LVESD in mm, LV end systolic diameter; LVESD, LV end systolic diameter; PWT, LV posterior wall thickness; Tei index, MPI=Myocardial performance index.